Cristina M. Ruas
Belo Horizonte, MG, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Effectiveness and Safety of Cannabis-Based Products for Refractory Epilepsy From Real-World Evidence.
Journal: Clinical therapeutics
Published: September 15, 2025
Drug Market in Brazil: An Analysis of Drug Discontinuation From 2018 to 2022.
Journal: Value in health regional issues
Published: July 20, 2025
Long COVID and Its Impacts: A Case-Control Study in Brazil.
Journal: Biomedicines
Published: May 20, 2025
Effectiveness of Clozapine Compared to Nonclozapine Antipsychotics in Older Adults With Schizophrenia in Brazil in a 16-Year Follow-Up.
Journal: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
Published: August 28, 2024
Sociodemographic, economic, and academic factors linked with resilience in university students during covid-19 pandemic: a Brazilian cross-sectional study.
Journal: BMC psychology
Published: August 08, 2024
Comparative effectiveness of clozapine and non-clozapine atypical antipsychotics provided by the Brazilian National Health System in adults with schizophrenia.
Journal: Frontiers in psychiatry
Published: April 22, 2024
Acceptability and consumers' willingness to pay for comprehensive medication management services in Brazil.
Journal: Journal of comparative effectiveness research
Published: February 08, 2024
Judicialization of cannabidiol-based products in Brazil: an analysis from 2019 to 2022
Journal: Cadernos de saude publica
Published: February 09, 2023
What we know about antibiotics prescribed by dentists in a Brazilian southeastern state.
Journal: Brazilian oral research
Published: January 15, 2021
Health equity and the usage of atypical antipsychotics within the Brazilian national health system: findings and implications.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: August 12, 2020
Last Updated: 09/26/2026